Many mutants of RAB31 have been detected in various types of human cancer (Supplementary information, Fig. S2e), and we were very curious to test whether any RAB31 mutant may also induce this localization of EGFR to CD63-positive MVEs. This evidence concerns the gene CD63 and cancer.